May 20
|
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
|
May 18
|
3 Monster Stocks in the Making You Can Buy Right Now
|
May 17
|
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
|
May 15
|
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
|
May 13
|
How Viking Therapeutics Stock Could 30x
|
May 13
|
Is Viking Therapeutics the Best Biotech Stock for You?
|
May 10
|
The 3 Best Russell 2000 Stocks to Buy in May 2024
|
May 9
|
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
|
May 7
|
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
|
May 6
|
Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
|
May 2
|
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
|
May 1
|
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
|
Apr 28
|
Is Viking Therapeutics Incredibly Undervalued?
|
Apr 28
|
Can This High-Flying Stock 10x in 10 Years?
|
Apr 26
|
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
|
Apr 26
|
3 Biotech Stocks to Buy on the Dip: April 2024
|
Apr 25
|
3 Millionaire-Maker Biotech Stocks
|
Apr 25
|
Q1 2024 Viking Therapeutics Inc Earnings Call
|
Apr 25
|
Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
|
Apr 24
|
Viking Therapeutics Reports First Quarter 2024 Results: Aligns with Analyst Projections
|